TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY™ (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symp
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| THERAPEUTICSMD, Inc. (NASDAQ: TXMD) | Delayed: 1.87 -0.03 (1.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.90 | 52 Week High | $11.26 | |||
| Open | $1.88 | 52 Week Low | $4.39 | |||
| Day High | $1.89 | P/E | N/A | |||
| Day Low | $1.87 | EPS | $-0.22 | |||
| Volume | 936 | |||||
